These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17671187)

  • 41. Arsenic trioxide (As(2)O(3)) inhibits peritoneal invasion of ovarian carcinoma cells in vitro and in vivo.
    Zhang J; Wang B
    Gynecol Oncol; 2006 Oct; 103(1):199-206. PubMed ID: 16624393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
    Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The C3G/Rap1 pathway promotes secretion of MMP-2 and MMP-9 and is involved in serous ovarian cancer metastasis.
    Che YL; Luo SJ; Li G; Cheng M; Gao YM; Li XM; Dai JM; He H; Wang J; Peng HJ; Zhang Y; Li WY; Wang H; Liu B; Linghu H
    Cancer Lett; 2015 Apr; 359(2):241-9. PubMed ID: 25617801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
    Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
    Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
    Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Chan HY; Cheung AN
    Histopathology; 2011 Dec; 59(6):1163-72. PubMed ID: 22175896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
    Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
    Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.
    Cao L; Shao M; Schilder J; Guise T; Mohammad KS; Matei D
    Oncogene; 2012 May; 31(20):2521-34. PubMed ID: 21963846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flow Cytometric Analysis of Ovarian Cancer Ascites: Response of Mesothelial Cells and Macrophages to Cancer.
    Hashimoto K; Honda K; Matsui H; Nagashima Y; Oda H
    Anticancer Res; 2016 Jul; 36(7):3579-84. PubMed ID: 27354626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells.
    Koya Y; Kajiyama H; Liu W; Shibata K; Senga T; Kikkawa F
    J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrin-linked kinase activity modulates the pro-metastatic behavior of ovarian cancer cells.
    Bruney L; Liu Y; Grisoli A; Ravosa MJ; Stack MS
    Oncotarget; 2016 Apr; 7(16):21968-81. PubMed ID: 26959113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting gonadotropin-releasing hormone receptor inhibits the early step of ovarian cancer metastasis by modulating tumor-mesothelial adhesion.
    Cheung LW; Yung S; Chan TM; Leung PC; Wong AS
    Mol Ther; 2013 Jan; 21(1):78-90. PubMed ID: 23164934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Appearance of tissue transglutaminase in astrocytes in multiple sclerosis lesions: a role in cell adhesion and migration?
    van Strien ME; Drukarch B; Bol JG; van der Valk P; van Horssen J; Gerritsen WH; Breve JJ; van Dam AM
    Brain Pathol; 2011 Jan; 21(1):44-54. PubMed ID: 20731658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HOXA9 promotes homotypic and heterotypic cell interactions that facilitate ovarian cancer dissemination via its induction of P-cadherin.
    Ko SY; Naora H
    Mol Cancer; 2014 Jul; 13():170. PubMed ID: 25023983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells.
    Mangala LS; Fok JY; Zorrilla-Calancha IR; Verma A; Mehta K
    Oncogene; 2007 Apr; 26(17):2459-70. PubMed ID: 17043648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chondroitin Sulfate Proteoglycan 4 Provides New Treatment Approach to Preventing Peritoneal Dissemination in Ovarian Cancer.
    Uno K; Koya Y; Yoshihara M; Iyoshi S; Kitami K; Sugiyama M; Miyamoto E; Mogi K; Fujimoto H; Yamakita Y; Wang X; Nawa A; Kajiyama H
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338902
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.
    Hwang JY; Mangala LS; Fok JY; Lin YG; Merritt WM; Spannuth WA; Nick AM; Fiterman DJ; Vivas-Mejia PE; Deavers MT; Coleman RL; Lopez-Berestein G; Mehta K; Sood AK
    Cancer Res; 2008 Jul; 68(14):5849-58. PubMed ID: 18632639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma.
    Bagatur Y; Ilter Akulke AZ; Bihorac A; Erdem M; Telci D
    Cell Adh Migr; 2018 Mar; 12(2):138-151. PubMed ID: 28498731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer.
    Sima LE; Chen S; Cardenas H; Zhao G; Wang Y; Ivan C; Huang H; Zhang B; Matei D
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34593619
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue transglutaminase activates integrin-linked kinase and β-catenin in ovarian cancer.
    Condello S; Prasad M; Atwani R; Matei D
    J Biol Chem; 2022 Aug; 298(8):102242. PubMed ID: 35810788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue transglutaminase promotes or suppresses tumors depending on cell context.
    Chhabra A; Verma A; Mehta K
    Anticancer Res; 2009 Jun; 29(6):1909-19. PubMed ID: 19528447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.